Search research articles
Contact Us
Filters
Showing results (11-20 of 273) with videos related to
Page
of 28
Sort By:
Biochemical Pharmacology
|
January 1, 1978
Lysolecithin is a selective reversible inhibitor of mitochondrial monoamine oxidase
M D Houslay
Progress in Nucleic Acid Research and Molecular Biology
|
September 12, 2001
PDE4 cAMP-specific phosphodiesterases
M D Houslay
The Proceedings of the Nutrition Society
|
July 1, 1985
Regulation of adenylate cyclase (EC 4.6.I.I) activity by its lipid environment
M D Houslay
Advances in Cyclic Nucleotide Research
|
January 1, 1981
Mobile receptor and collision coupling mechanisms for the activation of adenylate cyclase by glucagon
M D Houslay
Cellular Signalling
|
January 1, 1990
The use of selective inhibitors and computer modelling to evaluate the role of specific high affinity cyclic AMP phosphodiesterases in the hormonal regulation of hepatocyte intracellular cyclic AMP concentrations
M D Houslay
European Journal of Biochemistry
|
January 1, 1991
'Crosstalk': a pivotal role for protein kinase C in modulating relationships between signal transduction pathways
M D Houslay
Current Opinion in Cell Biology
|
August 1, 1989
Strategies for identifying functionally active domains upon cell surface receptors
M D Houslay
Molecular Pharmacology
|
September 22, 2000
Cell-type specific integration of cross-talk between extracellular signal-regulated kinase and cAMP signaling
M D Houslay, W Kolch
The Biochemical Journal
|
May 1, 1993
The role of Gi and the membrane-fluidizing agent benzyl alcohol in modulating the hysteretic activation of human platelet adenylate cyclase by guanylyl 5'-imidodiphosphate
S Spence, M D Houslay
The Biochemical Journal
|
January 1, 1997
Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant
S Erdogan, M D Houslay
Page
of 28
Search research articles
Search
Showing results (11-20 of 273) with videos related to
Sort By:
Page
of 28
Biochemical Pharmacology
|
January 1, 1978
Lysolecithin is a selective reversible inhibitor of mitochondrial monoamine oxidase
M D Houslay
Progress in Nucleic Acid Research and Molecular Biology
|
September 12, 2001
PDE4 cAMP-specific phosphodiesterases
M D Houslay
The Proceedings of the Nutrition Society
|
July 1, 1985
Regulation of adenylate cyclase (EC 4.6.I.I) activity by its lipid environment
M D Houslay
Advances in Cyclic Nucleotide Research
|
January 1, 1981
Mobile receptor and collision coupling mechanisms for the activation of adenylate cyclase by glucagon
M D Houslay
Cellular Signalling
|
January 1, 1990
The use of selective inhibitors and computer modelling to evaluate the role of specific high affinity cyclic AMP phosphodiesterases in the hormonal regulation of hepatocyte intracellular cyclic AMP concentrations
M D Houslay
European Journal of Biochemistry
|
January 1, 1991
'Crosstalk': a pivotal role for protein kinase C in modulating relationships between signal transduction pathways
M D Houslay
Current Opinion in Cell Biology
|
August 1, 1989
Strategies for identifying functionally active domains upon cell surface receptors
M D Houslay
Molecular Pharmacology
|
September 22, 2000
Cell-type specific integration of cross-talk between extracellular signal-regulated kinase and cAMP signaling
M D Houslay, W Kolch
The Biochemical Journal
|
May 1, 1993
The role of Gi and the membrane-fluidizing agent benzyl alcohol in modulating the hysteretic activation of human platelet adenylate cyclase by guanylyl 5'-imidodiphosphate
S Spence, M D Houslay
The Biochemical Journal
|
January 1, 1997
Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant
S Erdogan, M D Houslay
Page
of 28